371 related articles for article (PubMed ID: 33704407)
1. The latitude gradient for multiple sclerosis prevalence is established in the early life course.
Sabel CE; Pearson JF; Mason DF; Willoughby E; Abernethy DA; Taylor BV
Brain; 2021 Aug; 144(7):2038-2046. PubMed ID: 33704407
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis in New Zealand.
Alla S; Mason DF
J Clin Neurosci; 2014 Aug; 21(8):1288-91. PubMed ID: 24503208
[TBL] [Abstract][Full Text] [Related]
3. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis.
Simpson S; Wang W; Otahal P; Blizzard L; van der Mei IAF; Taylor BV
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1193-1200. PubMed ID: 31217172
[TBL] [Abstract][Full Text] [Related]
4. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.
Simpson S; Blizzard L; Otahal P; Van der Mei I; Taylor B
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1132-41. PubMed ID: 21478203
[TBL] [Abstract][Full Text] [Related]
5. MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
Taylor BV; Pearson JF; Clarke G; Mason DF; Abernethy DA; Willoughby E; Sabel C
Mult Scler; 2010 Dec; 16(12):1422-31. PubMed ID: 20813774
[TBL] [Abstract][Full Text] [Related]
6. Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?
Koch-Henriksen N; Sorensen PS
J Neurol Sci; 2011 Dec; 311(1-2):58-63. PubMed ID: 21982346
[TBL] [Abstract][Full Text] [Related]
7. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study.
Zivadinov R; Iona L; Monti-Bragadin L; Bosco A; Jurjevic A; Taus C; Cazzato G; Zorzon M
Neuroepidemiology; 2003; 22(1):65-74. PubMed ID: 12566956
[TBL] [Abstract][Full Text] [Related]
8. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
O'Connell K; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
[TBL] [Abstract][Full Text] [Related]
9. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Hammond SR; English DR; McLeod JG
Brain; 2000 May; 123 ( Pt 5)():968-74. PubMed ID: 10775541
[TBL] [Abstract][Full Text] [Related]
10. Geographical variations in sex ratio trends over time in multiple sclerosis.
Trojano M; Lucchese G; Graziano G; Taylor BV; Simpson S; Lepore V; Grand'maison F; Duquette P; Izquierdo G; Grammond P; Amato MP; Bergamaschi R; Giuliani G; Boz C; Hupperts R; Van Pesch V; Lechner-Scott J; Cristiano E; Fiol M; Oreja-Guevara C; Saladino ML; Verheul F; Slee M; Paolicelli D; Tortorella C; D'Onghia M; Iaffaldano P; Direnzo V; Butzkueven H;
PLoS One; 2012; 7(10):e48078. PubMed ID: 23133550
[TBL] [Abstract][Full Text] [Related]
11. The increasing prevalence of multiple sclerosis in New Zealand.
Alla S; Pearson J; Debernard L; Miller D; Mason D
Neuroepidemiology; 2014; 42(3):154-60. PubMed ID: 24556851
[TBL] [Abstract][Full Text] [Related]
12. High prevalence and no latitude gradient of multiple sclerosis in Norway.
Berg-Hansen P; Moen SM; Harbo HF; Celius EG
Mult Scler; 2014 Nov; 20(13):1780-2. PubMed ID: 24603884
[TBL] [Abstract][Full Text] [Related]
13. Latitudinal prevalence gradient of multiple sclerosis in Latin America.
Risco J; Maldonado H; Luna L; Osada J; Ruiz P; Juarez A; Vizcarra D
Mult Scler; 2011 Sep; 17(9):1055-9. PubMed ID: 21551216
[TBL] [Abstract][Full Text] [Related]
14. Digital epidemiology confirms a latitude gradient of MS in France.
Dalla Costa G; Giordano A; Romeo M; Sangalli F; Comi G; Martinelli V
Mult Scler Relat Disord; 2018 Feb; 20():129-131. PubMed ID: 29414285
[TBL] [Abstract][Full Text] [Related]
15. [The prevalence of multiple sclerosis in the city of Ourense, Galicia, in the north-west of the Iberian Peninsula].
García-Estévez DA; Fraga-González C; Ramos-Pacho ME; López-Díaz LM; Pardo-Parrado M; Prieto JM
Rev Neurol; 2020 Jul; 71(1):19-25. PubMed ID: 32583411
[TBL] [Abstract][Full Text] [Related]
16. The changing demographic pattern of multiple sclerosis epidemiology.
Koch-Henriksen N; Sørensen PS
Lancet Neurol; 2010 May; 9(5):520-32. PubMed ID: 20398859
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
Hollingworth S; Walker K; Page A; Eadie M
Mult Scler; 2013 Nov; 19(13):1712-6. PubMed ID: 23530000
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
[TBL] [Abstract][Full Text] [Related]
19. Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Grytten N; Torkildsen Ø; Aarseth JH; Benjaminsen E; Celius EG; Dahl OP; Holmøy T; Løken-Amsrud K; Midgard R; Myhr KM; Risberg G; Vatne A; Kampman MT
Mult Scler; 2013 Jul; 19(8):1028-34. PubMed ID: 23257620
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand.
Alla S; Pearson JF; Taylor BV; Roxburgh R; Clarke G; Miller DH; Richardson A; Abernethy DA; Willoughby E; Sabel CE; Mason DF
Mult Scler; 2016 Apr; 22(5):705-7. PubMed ID: 26432856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
